BVIG’s primary focus is the development of long-acting, protein-based smart drug delivery peptides to carry, target and deliver neurologic drug therapies.
Stage
Product In Development
Industry
Biotechnology
Location
Miami, FL, US
Currency
USD
Founded
October 2015
Employees
5
Company Summary
Biotechnology start-up organized as Florida C-Corporation.
BVIG will develop a technology platform and generate revenues by licensing products emanating from it. Both traditional licensing and Co-development collaboration agreements will be sought. We will seek co-promotion agreements for launched products.
We are developing a new drug platform to target disease applications like Alzheimer's Disease, ALS and other neuromuscular pathologies.